|
(R)-Lipoic Acid
by Jim English
Alpha-lipoic acid (ALA) is a unique, vitamin-like
antioxidant that can combat radiation sickness, repair damaged livers,
treat diabetes and diabetes-related conditions (polyneuropathy)
and protect against oxidative processes that promote premature aging
and degenerative diseases. ALA is becoming increasingly recognized
as a 'mitochondrial antioxidant.' Now a more potent form of ALA—R-lipoic
acid—is available to health consumers. Research shows that
(R)-lipoic acid is a more biologically active form of ALA that offers
greater antioxidant and neuroprotective benefits at substantially
lower doses than the synthetic forms of lipoic acid currently available.
Although lipoic acid is produced naturally in the body, researchers
were virtually unaware of its existence until the 1930s. When pure
samples were isolated in the 1950s, ALA was first believed to be
a new vitamin. Later, researchers discovered that ALA is, in fact,
an essential coenzyme with a vital role in mitochondrial electron
transport reactions involved in converting glucose into ATP to produce
energy. By 1988 researchers had also learned that ALA is a powerful
biological antioxidant, although one with some very unique health
properties. What most impressed researchers was the discovery that
ALA functions as both a fat and water-soluble antioxidant that can
easily cross cell membranes. Thus, ALA can confer free radical protection
to both interior and exterior cellular structures.
Human aging is marked by a decline in the concentration, synthesis
and recycling of central antioxidants, such as vitamin E, vitamin
C, co-enzyme Q-10 and glutathione. This loss of antioxidant function
seriously impairs the body's ability to control free radicals. Left
unchecked, free radicals—dangerous, unpaired electrons—proliferate
throughout the body, damaging cell membranes and organs, impairing
immune function, disrupting DNA strands and contributing to the
progression of cancer and other degenerative diseases. In recent
years researchers have shown how alpha-lipoic acid recycles vitamins
E and C to stave off free radical damage.
One of the central components in the antioxidant
cycle is vitamin E, a potent biological antioxidant that works to
stabilize highly reactive free radicals in lipid (fatty) tissues
and membranes (lipoproteins). In the process of quenching fatty
free radicals, such as lipid peroxyl and lipid alkoxyl radicals,
vitamin E becomes a free radical itself, though one that is far
less reactive or damaging than the original radical (Fig. 1).
The vitamin E radical is then regenerated by vitamin
C (ascorbic acid). This process recycles vitamin E from a radical
back into an antioxidant again, but results in the formation of
a new free radical in the form of unstable vitamin C—a semiascorbyl
radical. Vitamin C is next recycled by glutathione, a thiol (sulfur-containing
compound). Up to this point vitamins E, C and glutathione work in
concert to control free radicals and prevent cellular damage. But
this is also an important stage where the antioxidant regeneration
cycle runs into a limiting factor determined by the availability
of glutathione.
Glutathione is the most important member of the thiol group and
the body's primary intracellular antioxidant. In addition to being
an important free-radical deactivator, glutathione also plays a
vital role in protecting against cataract formation, enhancing immune
function, preventing liver damage, slowing the initiation of cancers
and eliminating heavy metals. Glutathione is quickly depleted when
the body experiences high levels of oxidative stress from causes
such as illness, infection, trauma, medication or surgery. Glutathione
deficiency is also associated with low protein intake, diabetes,
liver disease, cataracts, HIV infection, respiratory distress syndrome,
cancer, and idiopathic pulmonary fibrosis.
Dr. Lester Packer, senior scientist at Lawrence Berkeley Laboratory
and head of the Packer Lab at the University of California, has
spent over 35 years studying how antioxidants like vitamins C, E
and glutathione interact in the body. Dr. Packer first discovered
several years ago how vitamin E is 'recycled' by vitamin C.
Despite their detailed understanding of the antioxidant
regeneration cycle, when Dr. Packer and other researchers tested
methods for boosting antioxidant levels they ran into a problem
when attempting to increase cellular glutathione levels. Whereas
increasing one's intake of dietary or supplemental sources can readily
elevate levels of vitamins E and C, cellular glutathione is only
produced in the body. Glutathione, when taken orally, is broken
down in the stomach before reaching the bloodstream. What does end
up being absorbed can raise serum levels, but the effect inside
of cells is minimal.
This problem was solved when Packer and his team
turned to ALA. 'Alpha-lipoic acid proved to be the missing link,'
Packer said. They discovered that in addition to being a powerful
antioxidant in its own right, ALA is able to raise intracellular
glutathione levels. ALA is easily absorbed when taken orally, and
once inside cells it is quickly converted to its most potent form,
dihydrolipoic acid, an even more potent free-radical neutralizer.
Because both alpha-lipoic acid and dihydrolipoic acid are antioxidants,
their combined actions give them greater antioxidant potency than
any other natural antioxidant now known.
According to Dr. Packer, ALA is more potent than vitamins C and
E, and CoQ10, and may, in fact, be the most important antioxidant
ever discovered. "The therapeutic potential of alpha-lipoic
acid is just beginning to be explored,' observed Packer, 'but this
compound holds great promise."
ALA also is important in cell metabolism and is
required for production of energy inside cells. Without ALA, cells
could not metabolize sugars for energy and would just shut down.
This makes alpha-lipoic acid a metabolic antioxidant, able to draw
on the cell's own metabolism to magnify its protective effects and
that of other antioxidants.
Experiments carried out by Dr. Packer and colleagues
suggest that ALA may also have much broader use in treating other
diseases and may have general health benefits when taken as a daily
supplement like other antioxidants. 'Alpha-lipoic acid could have
far-reaching consequences in the search for prevention and therapy
of chronic degenerative diseases such as diabetes and cardiovascular
disease,' stated Dr. Packer. 'And because it's the only antioxidant
that can easily get into the brain, it could be useful in preventing
damage from a stroke.'
Natural ALA, referred to as R-lipoic acid or (R)-ALA, is found in
exceedingly miniscule amounts in animal and plant tissues, tightly
bound to mitochondrial complexes. Because of the extreme difficulty
(and high cost) of isolating natural (R)-ALA, researchers in the
US and Europe originally conducted studies with synthetic lipoic
acid. Unlike natural (R)-ALA, synthetic lipoic acid contains a 50/50
mixture of two forms (enantiomers) called (R)-ALA and (S)-ALA. Both
(R)- and (S)- forms of ALA are isomers—essentially mirror-image
molecular formulas, with the atomic arrangements reversed.
Working with synthetic ALA, researchers were able
to gain valuable insights into its role as a coenzyme in mitochondrial
energy production, and an antioxidant and antioxidant-recycling
nutrient. They then began to map out the impressive range of protective
health benefits conferred by supplemental ALA. In time researchers
had access to pure samples of the natural, biological version, (R)-ALA.
They quickly learned that while the body can utilize both forms
of ALA, there is a strong preference for the natural, more biologically
active (R) form. For example, researchers in Germany reported that,
unlike the natural form, (S)-ALA does not improve ATP synthesis
in isolated cells. Furthermore, the R-form increased membrane fluidity
and transport, while the S-form tended to decrease fluidity.
R-lipoic acid is the biologically active form of the key 'mitochondrial
antioxidant,' alpha lipoic acid. R-lipoic acid is directly involved
in cellular metabolism and is a vital component of the intracellular
antioxidant cycle, able to scavenge a variety of free radicals and
reactive oxygen species (ROS) while recycling vitamins C, E and
glutathione. R-lipoic readily crosses the blood brain barrier and
has been shown effective for elevating intracellular glutathione
levels. R-LA helps regulate neuronal calcium homeostasis, regulates
pro-inflammatory cytokines, and alters the expression of 'toxic
genes.' R-lipoic acid has been used to treat diabetes and has been
recommended as a "neuroprotective agent." Because R-lipoic
is the naturally occurring form found in mitochondrial complexes
it offers substantially greater antioxidant and neuroprotective
benefits at substantially lower doses than the synthetic forms of
lipoic acid currently available.
References
1. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic
antioxidant alpha-lipoic acid. Free Radic Biol Med 1997;22(1-2):359-78.
2. L. Packer, E.H.Witt, H.J. Tritschler, Free Rad Biol and Med 1995;
19: 227-250.
3. Lykkesfeldt J, Hagen TM, Vinarsky V, Ames BN. Age-associated
decline in ascorbic acid concentration, recycling, and biosynthesis
in rat hepatocytes--reversal with (R)-alpha-lipoic acid supplementation.
FASEB J 1998 Sep;12(12):1183-9.
4. Liu J, Atamna H, Kuratsune H, Ames BN. Delaying brain mitochondrial
decay and aging with mitochondrial antioxidants and metabolites.
Ann N Y Acad Sci 2002 Apr;959:133-66.
5. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman
CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial
decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine
and/or R-alpha -lipoic acid. Proc Natl Acad Sci USA 2002 Feb 19;99(4):2356-61.
6. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky
V, Bartholomew JC, Ames BN. Feeding acetyl-L-carnitine and lipoic
acid to old rats significantly improves metabolic function while
decreasing oxidative stress. Proc Natl Acad Sci USA 2002 Feb 19;99(4):1870-5.
7. Hofmann M, Mainka P, Tritschler H, Fuchs J, Zimmer G. Decrease
of red cell membrane fluidity and -SH groups due to hyperglycemic
conditions is counteracted by alpha-lipoic acid. Arch Biochem Biophys
1995 Dec 1;324(1):85-92.
8. Haramaki N, Assadnazari H, Zimmer G, Schepkin V, Packer L. The
influence of vitamin E and dihydrolipoic acid on cardiac energy
and glutathione status under hypoxia-reoxygenation. Biochem Mol
Biol Int 1995 Oct;37(3):591-7. 9. Zimmer G, Beikler TK, Schneider
M, Ibel J, Tritschler H, Ulrich H. Dose/response curves of lipoic
acid R-and S-forms in the working rat heart during reoxygenation:
superiority of the R-enantiomer in enhancement of aortic flow. J
Mol Cell Cardiol 1995 Sep;27(9):1895-903.
10. Haramaki N, Packer L, Assadnazari H, Zimmer G. Cardiac recovery
during post-ischemic reperfusion is improved by combination of vitamin
E with dihydrolipoic acid. Biochem Biophys Res Commun 1993 Nov 15;196(3):1101-7.
11. Moini, H., Tirosh, O., R-Alpha Lipoic Acid Action on Cell Redox
Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes;
Archives of Biochem & BioPhys 397, No2 384-391 (2002).
12. Liu, J. Killilea, D.W. et.al., Age-associated mitochondrial
oxidative decay: Improvement of carnitine acetyltransferase substrate
binding affinity and activity in brain by feeding old rats acetyl-L-carnitine
and/or R-alpha-lipoic acid. Proc Nat Acad Sci 99, 1876-1881 (2002).
13. Hager, K., Marahrens, A.,et.al. Alpha lipoic acid as a new treatment
option for Alzheimer type dementia, Arch Geron Geriatr 32 (3): 275-282
(2001).
14. Hermann, R.; Niebch, G.; Enantioselective pharmacokinetics and
bioavailability of different racemic alpha lipoic acid formulations
in healthy volunteers. Eur J Pharm Sci 4: 167-174 (1996). |